サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1459781

バイオマーカー市場：世界の産業分析、規模、シェア、成長、動向、2023年～2031年予測

Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 201 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
バイオマーカー市場：世界の産業分析、規模、シェア、成長、動向、2023年～2031年予測
出版日: 2024年02月23日
発行: Transparency Market Research
ページ情報: 英文 201 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオマーカー市場- 調査範囲

TMRの世界バイオマーカー市場に関する調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。本レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの世界のバイオマーカー市場の収益を提供しています。また、2023年から2031年までの世界のバイオマーカー市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、バイオマーカー市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照しました。

市場スナップショット
2022年の市場規模 512億米ドル
2031年の市場価値 1,256億米ドル
CAGR 10.4%

本レポートでは、世界のバイオマーカー市場の競合情勢について掘り下げています。世界のバイオマーカー市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイリングされています。企業概要、財務状況、最近の市場開拓、SWOTは本レポートで紹介されているバイオマーカーの世界市場における企業の属性です。

目次

第1章 序文

第2章 調査前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • 世界市場の分析と予測、2017年～2031年

第5章 キー洞察

  • 技術の進歩
  • 世界における疾患の有病率と罹患率、主要国別
  • 地域別/世界全体の規制シナリオ
  • COVID-19インパクト分析

第6章 世界市場分析と予測：製品・サービス別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：製品・サービス別、2017年～2031年
    • 消耗品
    • サービス
    • 機器
  • 製品・サービス別市場魅力度

第7章 世界市場分析・予測：適応疾患別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 用途別市場金額予測、2017年～2031年
    • 診断薬
    • 創薬・医薬品開発
    • 個別化医療
    • 疾病リスク評価
    • その他
  • 用途別市場魅力度

第8章 世界市場分析と予測：タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • タイプ別市場金額予測、2017年～2031年
    • 安全性
    • 感受性/リスク
    • 診断薬
    • 予後
    • モニタリング
    • 予測
    • 薬力学／反応
  • タイプ別市場魅力度

第9章 世界市場分析・予測：適応疾患別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 疾患適応症別市場金額予測、2017年～2031年
    • がん
    • 神経疾患
    • 心血管疾患
    • 感染症
    • 免疫疾患
    • その他
  • 適応疾患別の市場魅力度

第10章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 地域別市場金額予測
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別市場魅力度

第11章 北米市場の分析と予測

  • 米国
  • カナダ

第12章 欧州市場の分析と予測

  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他の欧州

第13章 アジア太平洋市場の分析と予測

  • 中国
  • 日本
  • インド
  • オーストラリア・ニュージーランド
  • その他のアジア太平洋

第14章 ラテンアメリカ市場の分析と予測ラテンアメリカ市場の分析と予測

  • ブラジル
  • メキシコ
  • その他のラテンアメリカ

第15章 中東・アフリカ市場の分析と予測

  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

第16章 競合情勢

  • 企業シェア分析（2022年）
  • 企業プロファイル
    • Abbott Laboratories
    • Agilent Technology
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories
    • BioMerieux SA（Astute Medical）
    • Merck KGaA
    • Qiagen NV
    • Quanterix
    • Quest Diagnostics
    • Thermo Fisher Scientific Inc.
図表

List of Tables

  • Table 01: Global Biomarkers Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
  • Table 02: Global Biomarkers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Biomarkers Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 04: Global Biomarkers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 05: Global Biomarkers Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Biomarkers Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Biomarkers Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
  • Table 08: North America Biomarkers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 09: North America Biomarkers Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 10: North America Biomarkers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 11: Europe Biomarkers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Biomarkers Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
  • Table 13: Europe Biomarkers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 14: Europe Biomarkers Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 15: Europe Biomarkers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 16: Asia Pacific Biomarkers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Biomarkers Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
  • Table 18: Asia Pacific Biomarkers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 19: Asia Pacific Biomarkers Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 20: Asia Pacific Biomarkers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 21: Latin America Biomarkers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Biomarkers Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
  • Table 23: Latin America Biomarkers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Latin America Biomarkers Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 25: Latin America Biomarkers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 26: Middle East & Africa Biomarkers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Biomarkers Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
  • Table 28: Middle East & Africa Biomarkers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 29: Middle East & Africa Biomarkers Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 30: Middle East & Africa Biomarkers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031

List of Figures

  • Figure 01: Global Biomarkers Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Biomarkers Market Value Share, by Product & Service, 2022
  • Figure 03: Global Biomarkers Market Value Share, by Application, 2022
  • Figure 04: Global Biomarkers Market Value Share, by Type, 2022
  • Figure 05: Global Biomarkers Market Value Share, by Disease Indication, 2022
  • Figure 06: Global Biomarkers Market Value Share, by Region, 2022
  • Figure 07: Global Biomarkers Market Value (US$ Mn) Share Analysis, by Product & Service, 2022-2031
  • Figure 08: Global Biomarkers Market Share Analysis, by Product & Service, 2022
  • Figure 09: Global Biomarkers Market Share Analysis, by Product & Service, 2031
  • Figure 10: Global Biomarkers Market Attractiveness Analysis, by Product & Service, 2023-2031
  • Figure 11: Global Biomarkers Market Value (US$ Mn), by Consumables, 2017-2031
  • Figure 12: Global Biomarkers Market Value Share Analysis, by Consumables, 2022-2031
  • Figure 13: Global Biomarkers Market Value (US$ Mn), by Services, 2017-2031
  • Figure 14: Global Biomarkers Market Value Share Analysis, by Services, 2022-2031
  • Figure 15: Global Biomarkers Market Value (US$ Mn), by Equipment, 2017-2031
  • Figure 16: Global Biomarkers Market Value Share Analysis, by Equipment, 2022-2031
  • Figure 17: Global Biomarkers Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
  • Figure 18: Global Biomarkers Market Share Analysis, by Application, 2022
  • Figure 19: Global Biomarkers Market Share Analysis, by Application, 2031
  • Figure 20: Global Biomarkers Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 21: Global Biomarkers Market Value (US$ Mn), by Diagnostics, 2017-2031
  • Figure 22: Global Biomarkers Market Value Share Analysis, by Diagnostics, 2022-2031
  • Figure 23: Global Biomarkers Market Value (US$ Mn), by Drug Discovery & Development, 2017-2031
  • Figure 24: Global Biomarkers Market Value Share Analysis, by Drug Discovery & Development, 2022-2031
  • Figure 25: Global Biomarkers Market Value (US$ Mn), by Personalized Medicine, 2017-2031
  • Figure 26: Global Biomarkers Market Value Share Analysis, by Personalized Medicine, 2022-2031
  • Figure 27: Global Biomarkers Market Value (US$ Mn), by Disease Risk Assessment, 2017-2031
  • Figure 28: Global Biomarkers Market Value Share Analysis, by Disease Risk Assessment, 2022-2031
  • Figure 29: Global Biomarkers Market Value (US$ Mn), by Others, 2017-2031
  • Figure 30: Global Biomarkers Market Value Share Analysis, by Others, 2022-2031
  • Figure 31: Global Biomarkers Market Value (US$ Mn) Share Analysis, by Type, 2022-2031
  • Figure 32: Global Biomarkers Market Share Analysis, by Type, 2022
  • Figure 33: Global Biomarkers Market Share Analysis, by Type, 2031
  • Figure 34: Global Biomarkers Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 35: Global Biomarkers Market Value (US$ Mn), by Safety Biomarkers, 2017-2031
  • Figure 36: Global Biomarkers Market Value Share Analysis, by Safety Biomarkers, 2022-2031
  • Figure 37: Global Biomarkers Market Value (US$ Mn), by Susceptibility/Risk Biomarkers, 2017-2031
  • Figure 38: Global Biomarkers Market Value Share Analysis, by Susceptibility/Risk Biomarkers, 2022-2031
  • Figure 39: Global Biomarkers Market Value (US$ Mn), by Diagnostic Biomarkers, 2017-2031
  • Figure 40: Global Biomarkers Market Value Share Analysis, by Diagnostic Biomarkers, 2022-2031
  • Figure 41: Global Biomarkers Market Value (US$ Mn), by Prognostic Biomarkers, 2017-2031
  • Figure 42: Global Biomarkers Market Value Share Analysis, by Prognostic Biomarkers, 2022-2031
  • Figure 43: Global Biomarkers Market Value (US$ Mn), by Monitoring Biomarkers, 2017-2031
  • Figure 44: Global Biomarkers Market Value Share Analysis, by Monitoring Biomarkers, 2022-2031
  • Figure 45: Global Biomarkers Market Value (US$ Mn), by Predictive Biomarkers, 2017-2031
  • Figure 46: Global Biomarkers Market Value Share Analysis, by Predictive Biomarkers, 2022-2031
  • Figure 47: Global Biomarkers Market Value (US$ Mn), by Pharmacodynamic/Response Biomarkers, 2017-2031
  • Figure 48: Global Biomarkers Market Value Share Analysis, by Pharmacodynamic/Response Biomarkers, 2022-2031
  • Figure 49: Global Biomarkers Market Value (US$ Mn) Share Analysis, by Disease Indication, 2022-2031
  • Figure 50: Global Biomarkers Market Share Analysis, by Disease Indication, 2022
  • Figure 51: Global Biomarkers Market Share Analysis, by Disease Indication, 2031
  • Figure 52: Global Biomarkers Market Attractiveness Analysis, by Disease Indication, 2023-2031
  • Figure 53: Global Biomarkers Market Value (US$ Mn), by Cancer, 2017-2031
  • Figure 54: Global Biomarkers Market Value Share Analysis, by Cancer, 2022-2031
  • Figure 55: Global Biomarkers Market Value (US$ Mn), by Neurological Disorders, 2017-2031
  • Figure 56: Global Biomarkers Market Value Share Analysis, by Neurological Disorders, 2022-2031
  • Figure 57: Global Biomarkers Market Value (US$ Mn), by Cardiovascular Disorders, 2017-2031
  • Figure 58: Global Biomarkers Market Value Share Analysis, by Cardiovascular Disorders, 2022-2031
  • Figure 59: Global Biomarkers Market Value (US$ Mn), by Infectious Diseases, 2017-2031
  • Figure 60: Global Biomarkers Market Value Share Analysis, by Infectious Diseases, 2022-2031
  • Figure 61: Global Biomarkers Market Value (US$ Mn), by Immune Disorders, 2017-2031
  • Figure 62: Global Biomarkers Market Value Share Analysis, by Immune Disorders, 2022-2031
  • Figure 63: Global Biomarkers Market Value (US$ Mn), by Others, 2017-2031
  • Figure 64: Global Biomarkers Market Value Share Analysis, by Others, 2022-2031
  • Figure 65: Global Biomarkers Market Value Share Analysis, by Region, 2022-2031
  • Figure 66: Global Biomarkers Market Share Analysis, by Region, 2022
  • Figure 67: Global Biomarkers Market Share Analysis, by Region, 2031
  • Figure 68: Global Biomarkers Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 69: North America Biomarkers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 70: North America Biomarkers Market Value Share Analysis, by Country, 2022-2031
  • Figure 71: North America Biomarkers Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 72: North America Biomarkers Market Value (US$ Mn) Share Analysis, by Product & Service, 2022-2031
  • Figure 73: North America Biomarkers Market Attractiveness Analysis, by Product & Service, 2023-2031
  • Figure 74: North America Biomarkers Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
  • Figure 75: North America Biomarkers Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 76: North America Biomarkers Market Value (US$ Mn) Share Analysis, by Type, 2022-2031
  • Figure 77: North America Biomarkers Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 78: North America Biomarkers Market Value (US$ Mn) Share Analysis, by Type, 2022-2031
  • Figure 79: North America Biomarkers Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 80: Europe Biomarkers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 81: Europe Biomarkers Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 82: Europe Biomarkers Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 83: Europe Biomarkers Market Value (US$ Mn) Share Analysis, by Product & Service, 2022-2031
  • Figure 84: Europe Biomarkers Market Attractiveness Analysis, by Product & Service, 2023-2031
  • Figure 85: Europe Biomarkers Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
  • Figure 86: Europe Biomarkers Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 87: Europe Biomarkers Market Value (US$ Mn) Share Analysis, by Type, 2022-2031
  • Figure 88: Europe Biomarkers Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 89: Europe Biomarkers Market Value (US$ Mn) Share Analysis, by Type, 2022-2031
  • Figure 90: Europe Biomarkers Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 91: Asia Pacific Biomarkers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 92: Asia Pacific Biomarkers Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 93: Asia Pacific Biomarkers Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 94: Asia Pacific Biomarkers Market Value (US$ Mn) Share Analysis, by Product & Service, 2022-2031
  • Figure 95: Asia Pacific Biomarkers Market Attractiveness Analysis, by Product & Service, 2023-2031
  • Figure 96: Asia Pacific Biomarkers Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
  • Figure 97: Asia Pacific Biomarkers Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 98: Asia Pacific Biomarkers Market Value (US$ Mn) Share Analysis, by Type, 2022-2031
  • Figure 99: Asia Pacific Biomarkers Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 100: Asia Pacific Biomarkers Market Value (US$ Mn) Share Analysis, by Type, 2022-2031
  • Figure 101: Asia Pacific Biomarkers Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 102: Latin America Biomarkers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 103: Latin America Biomarkers Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 104: Latin America Biomarkers Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 105: Latin America Biomarkers Market Value (US$ Mn) Share Analysis, by Product & Service, 2022-2031
  • Figure 106: Latin America Biomarkers Market Attractiveness Analysis, by Product & Service, 2023-2031
  • Figure 107: Latin America Biomarkers Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
  • Figure 108: Latin America Biomarkers Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 109: Latin America Biomarkers Market Value (US$ Mn) Share Analysis, by Type, 2022-2031
  • Figure 110: Latin America Biomarkers Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 111: Latin America Biomarkers Market Value (US$ Mn) Share Analysis, by Type, 2022-2031
  • Figure 112: Latin America Biomarkers Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 113: Middle East & Africa Biomarkers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 114: Middle East & Africa Biomarkers Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 115: Middle East & Africa Biomarkers Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 116: Middle East & Africa Biomarkers Market Value (US$ Mn) Share Analysis, by Product & Service, 2022-2031
  • Figure 117: Middle East & Africa Biomarkers Market Attractiveness Analysis, by Product & Service, 2023-2031
  • Figure 118: Middle East & Africa Biomarkers Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
  • Figure 119: Middle East & Africa Biomarkers Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 120: Middle East & Africa Biomarkers Market Value (US$ Mn) Share Analysis, by Type, 2022-2031
  • Figure 121: Middle East & Africa Biomarkers Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 122: Middle East & Africa Biomarkers Market Value (US$ Mn) Share Analysis, by Type, 2022-2031
  • Figure 123: Middle East & Africa Biomarkers Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 124: Biomarkers Market: Company Share Analysis, 2022
目次
Product Code: TMRGL520

Biomarkers Market - Scope of Report

TMR's report on the global biomarkers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global biomarkers market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global biomarkers market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the biomarkers market.

Market Snapshot
Market Value in 2022US$ 51.2 Bn
Market Value in 2031US$ 125.6 Bn
CAGR10.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global biomarkers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global biomarkers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global biomarkers market.

The report delves into the competitive landscape of the global biomarkers market. Key players operating in the global biomarkers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global biomarkers market profiled in this report.

Key Questions Answered in Global biomarkers Market Report:

  • What is the sales/revenue generated by biomarkers across all regions during the forecast period?
  • What are the opportunities in the global biomarkers market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Biomarkers Market - Research Objectives and Research Approach

The comprehensive report on the global biomarkers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global biomarkers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global biomarkers market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Biomarkers Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Biomarkers Market Analysis and Forecasts, 2017-2031

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Disease Prevalence & Incidence Rate Globally with Key Countries
  • 5.3. Regulatory Scenario by Region/globally
  • 5.4. COVID-19 Impact Analysis

6. Global Biomarkers Market Analysis and Forecasts, By Product & Service

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product & Service, 2017-2031
    • 6.3.1. Consumables
    • 6.3.2. Services
    • 6.3.3. Equipment
  • 6.4. Market Attractiveness By Product & Service

7. Global Biomarkers Market Analysis and Forecasts, By Disease Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2017-2031
    • 7.3.1. Diagnostics
    • 7.3.2. Drug Discovery & Development
    • 7.3.3. Personalized Medicine
    • 7.3.4. Disease Risk Assessment
    • 7.3.5. Others
  • 7.4. Market Attractiveness By Application

8. Global Biomarkers Market Analysis and Forecasts, By Type

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Type, 2017-2031
    • 8.3.1. Safety Biomarkers
    • 8.3.2. Susceptibility/Risk Biomarkers
    • 8.3.3. Diagnostic Biomarkers
    • 8.3.4. Prognostic Biomarkers
    • 8.3.5. Monitoring Biomarkers
    • 8.3.6. Predictive Biomarkers
    • 8.3.7. Pharmacodynamic/Response Biomarkers
  • 8.4. Market Attractiveness By Type

9. Global Biomarkers Market Analysis and Forecasts, By Disease Indication

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Disease Indication, 2017-2031
    • 9.3.1. Cancer
    • 9.3.2. Neurological Disorders
    • 9.3.3. Cardiovascular Disorders
    • 9.3.4. Infectious Diseases
    • 9.3.5. Immune Disorders
    • 9.3.6. Others
  • 9.4. Market Attractiveness By Disease Indication

10. Global Biomarkers Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Biomarkers Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product & Service, 2017-2031
    • 11.2.1. Consumables
    • 11.2.2. Services
    • 11.2.3. Equipment
  • 11.3. Market Value Forecast By Application, 2017-2031
    • 11.3.1. Diagnostics
    • 11.3.2. Drug Discovery & Development
    • 11.3.3. Personalized Medicine
    • 11.3.4. Disease Risk Assessment
    • 11.3.5. Others
  • 11.4. Market Value Forecast By Type, 2017-2031
    • 11.4.1. Safety Biomarkers
    • 11.4.2. Susceptibility/Risk Biomarkers
    • 11.4.3. Diagnostic Biomarkers
    • 11.4.4. Prognostic Biomarkers
    • 11.4.5. Monitoring Biomarkers
    • 11.4.6. Predictive Biomarkers
    • 11.4.7. Pharmacodynamic/Response Biomarkers
  • 11.5. Market Value Forecast By Disease Indication, 2017-2031
    • 11.5.1. Cancer
    • 11.5.2. Neurological Disorders
    • 11.5.3. Cardiovascular Disorders
    • 11.5.4. Infectious Diseases
    • 11.5.5. Immune Disorders
    • 11.5.6. Others
  • 11.6. Market Value Forecast By Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product & Service
    • 11.7.2. By Application
    • 11.7.3. By Type
    • 11.7.4. By Disease Indication
    • 11.7.5. By Country

12. Europe Biomarkers Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product & Service, 2017-2031
    • 12.2.1. Consumables
    • 12.2.2. Services
    • 12.2.3. Equipment
  • 12.3. Market Value Forecast By Application, 2017-2031
    • 12.3.1. Diagnostics
    • 12.3.2. Drug Discovery & Development
    • 12.3.3. Personalized Medicine
    • 12.3.4. Disease Risk Assessment
    • 12.3.5. Others
  • 12.4. Market Value Forecast By Type, 2017-2031
    • 12.4.1. Safety Biomarkers
    • 12.4.2. Susceptibility/Risk Biomarkers
    • 12.4.3. Diagnostic Biomarkers
    • 12.4.4. Prognostic Biomarkers
    • 12.4.5. Monitoring Biomarkers
    • 12.4.6. Predictive Biomarkers
    • 12.4.7. Pharmacodynamic/Response Biomarkers
  • 12.5. Market Value Forecast By Disease Indication, 2017-2031
    • 12.5.1. Cancer
    • 12.5.2. Neurological Disorders
    • 12.5.3. Cardiovascular Disorders
    • 12.5.4. Infectious Diseases
    • 12.5.5. Immune Disorders
    • 12.5.6. Others
  • 12.6. Market Value Forecast By Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product & Service
    • 12.7.2. By Application
    • 12.7.3. By Type
    • 12.7.4. By Disease Indication
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Biomarkers Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product & Service, 2017-2031
    • 13.2.1. Consumables
    • 13.2.2. Services
    • 13.2.3. Equipment
  • 13.3. Market Value Forecast By Application, 2017-2031
    • 13.3.1. Diagnostics
    • 13.3.2. Drug Discovery & Development
    • 13.3.3. Personalized Medicine
    • 13.3.4. Disease Risk Assessment
    • 13.3.5. Others
  • 13.4. Market Value Forecast By Type, 2017-2031
    • 13.4.1. Safety Biomarkers
    • 13.4.2. Susceptibility/Risk Biomarkers
    • 13.4.3. Diagnostic Biomarkers
    • 13.4.4. Prognostic Biomarkers
    • 13.4.5. Monitoring Biomarkers
    • 13.4.6. Predictive Biomarkers
    • 13.4.7. Pharmacodynamic/Response Biomarkers
  • 13.5. Market Value Forecast By Disease Indication, 2017-2031
    • 13.5.1. Cancer
    • 13.5.2. Neurological Disorders
    • 13.5.3. Cardiovascular Disorders
    • 13.5.4. Infectious Diseases
    • 13.5.5. Immune Disorders
    • 13.5.6. Others
  • 13.6. Market Value Forecast By Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product & Service
    • 13.7.2. By Application
    • 13.7.3. By Type
    • 13.7.4. By Disease Indication
    • 13.7.5. By Country/Sub-region

14. Latin America Biomarkers Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product & Service, 2017-2031
    • 14.2.1. Consumables
    • 14.2.2. Services
    • 14.2.3. Equipment
  • 14.3. Market Value Forecast By Application, 2017-2031
    • 14.3.1. Diagnostics
    • 14.3.2. Drug Discovery & Development
    • 14.3.3. Personalized Medicine
    • 14.3.4. Disease Risk Assessment
    • 14.3.5. Others
  • 14.4. Market Value Forecast By Type, 2017-2031
    • 14.4.1. Safety Biomarkers
    • 14.4.2. Susceptibility/Risk Biomarkers
    • 14.4.3. Diagnostic Biomarkers
    • 14.4.4. Prognostic Biomarkers
    • 14.4.5. Monitoring Biomarkers
    • 14.4.6. Predictive Biomarkers
    • 14.4.7. Pharmacodynamic/Response Biomarkers
  • 14.5. Market Value Forecast By Disease Indication, 2017-2031
    • 14.5.1. Cancer
    • 14.5.2. Neurological Disorders
    • 14.5.3. Cardiovascular Disorders
    • 14.5.4. Infectious Diseases
    • 14.5.5. Immune Disorders
    • 14.5.6. Others
  • 14.6. Market Value Forecast By Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product & Service
    • 14.7.2. By Application
    • 14.7.3. By Type
    • 14.7.4. By Disease Indication
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Biomarkers Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Product & Service, 2017-2031
    • 15.2.1. Consumables
    • 15.2.2. Services
    • 15.2.3. Equipment
  • 15.3. Market Value Forecast By Application, 2017-2031
    • 15.3.1. Diagnostics
    • 15.3.2. Drug Discovery & Development
    • 15.3.3. Personalized Medicine
    • 15.3.4. Disease Risk Assessment
    • 15.3.5. Others
  • 15.4. Market Value Forecast By Type, 2017-2031
    • 15.4.1. Safety Biomarkers
    • 15.4.2. Susceptibility/Risk Biomarkers
    • 15.4.3. Diagnostic Biomarkers
    • 15.4.4. Prognostic Biomarkers
    • 15.4.5. Monitoring Biomarkers
    • 15.4.6. Predictive Biomarkers
    • 15.4.7. Pharmacodynamic/Response Biomarkers
  • 15.5. Market Value Forecast By Disease Indication, 2017-2031
    • 15.5.1. Cancer
    • 15.5.2. Neurological Disorders
    • 15.5.3. Cardiovascular Disorders
    • 15.5.4. Infectious Diseases
    • 15.5.5. Immune Disorders
    • 15.5.6. Others
  • 15.6. Market Value Forecast By Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product & Service
    • 15.7.2. By Application
    • 15.7.3. By Type
    • 15.7.4. By Disease Indication
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Share Analysis By Company (2022)
  • 16.2. Company Profiles
    • 16.2.1. Abbott Laboratories
      • 16.2.1.1. Company Overview
      • 16.2.1.2. Financial Overview
      • 16.2.1.3. Product Portfolio
      • 16.2.1.4. Business Strategies
      • 16.2.1.5. Recent Developments
    • 16.2.2. Agilent Technology
      • 16.2.2.1. Company Overview
      • 16.2.2.2. Financial Overview
      • 16.2.2.3. Product Portfolio
      • 16.2.2.4. Business Strategies
      • 16.2.2.5. Recent Developments
    • 16.2.3. Becton, Dickinson and Company
      • 16.2.3.1. Company Overview
      • 16.2.3.2. Financial Overview
      • 16.2.3.3. Product Portfolio
      • 16.2.3.4. Business Strategies
      • 16.2.3.5. Recent Developments
    • 16.2.4. Bio-Rad Laboratories
      • 16.2.4.1. Company Overview
      • 16.2.4.2. Financial Overview
      • 16.2.4.3. Product Portfolio
      • 16.2.4.4. Business Strategies
      • 16.2.4.5. Recent Developments
    • 16.2.5. BioMerieux SA (Astute Medical)
      • 16.2.5.1. Company Overview
      • 16.2.5.2. Financial Overview
      • 16.2.5.3. Product Portfolio
      • 16.2.5.4. Business Strategies
      • 16.2.5.5. Recent Developments
    • 16.2.6. Merck KGaA
      • 16.2.6.1. Company Overview
      • 16.2.6.2. Financial Overview
      • 16.2.6.3. Product Portfolio
      • 16.2.6.4. Business Strategies
      • 16.2.6.5. Recent Developments
    • 16.2.7. Qiagen NV
      • 16.2.7.1. Company Overview
      • 16.2.7.2. Financial Overview
      • 16.2.7.3. Product Portfolio
      • 16.2.7.4. Business Strategies
      • 16.2.7.5. Recent Developments
    • 16.2.8. Quanterix
      • 16.2.8.1. Company Overview
      • 16.2.8.2. Financial Overview
      • 16.2.8.3. Product Portfolio
      • 16.2.8.4. Business Strategies
      • 16.2.8.5. Recent Developments
    • 16.2.9. Quest Diagnostics
      • 16.2.9.1. Company Overview
      • 16.2.9.2. Financial Overview
      • 16.2.9.3. Product Portfolio
      • 16.2.9.4. Business Strategies
      • 16.2.9.5. Recent Developments
    • 16.2.10. Thermo Fisher Scientific Inc.
      • 16.2.10.1. Company Overview
      • 16.2.10.2. Financial Overview
      • 16.2.10.3. Product Portfolio
      • 16.2.10.4. Business Strategies
      • 16.2.10.5. Recent Developments